Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia

NCT05542095 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05542095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Withdrawn
Start date
May 1, 2023
Completion date
May 1, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, olfactory disorder